한글목차

만성 통증 치료 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 1,090억 5,000만 달러에서 2026년에는 1,193억 2,000만 달러로, CAGR 9.4%로 성장할 것으로 예상됩니다. 지난 몇 년간 성장 요인으로는 오피오이드 사용, 근골격계 질환, 고령화, 병원 통증 클리닉, 수술 후 통증 관리 등을 꼽을 수 있습니다.

만성 통증 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,689억 9,000만 달러에 달하고, CAGR은 9.1%가 될 전망입니다. 예측 기간의 성장 요인으로는 오피오이드 규제, 기기 기반 치료, 만성질환 유병률, 정신건강 통합, 외래 통증 치료의 확대 등이 꼽힙니다. 예측 기간의 주요 동향으로는 비오피오이드 진통제로의 전환, 신경조절장치의 성장, 다직종 협진을 통한 통증 관리의 확대, 개별화된 통증 치료에 대한 관심 증가, 심리적 지지요법의 통합 등을 들 수 있습니다.

관절염 통증의 유병률 증가는 향후 몇 년 동안 만성 통증 치료 시장의 성장을 견인할 것으로 예상됩니다. 관절염 통증은 관절염에 따른 염증과 퇴행으로 인해 발생하는 관절의 불편감, 통증 또는 둔통을 말합니다. 관절염 통증의 유병률이 증가하는 주요 요인은 고령화 사회로 인해 나이가 들면서 관절의 마모가 자연적으로 진행되어 관절염 관련 질환의 발병률이 높아지고 있기 때문입니다. 만성 통증 치료는 염증과 신경과민을 표적으로 삼아 관절염의 통증에 접근하여 지속적인 증상을 가진 환자들의 불편감 감소, 관절 기능 개선, 그리고 전반적인 삶의 질 향상에 기여합니다. 예를 들어, 미국 질병예방통제센터(CDC)의 2024년 7월 기준 추산에 따르면, 2023년 미국에서 관절염 진단을 받은 18세 이상 성인은 전체의 약 21.2%에 달했습니다. 따라서 관절염으로 인한 통증의 유병률 증가가 만성 통증 치료 시장의 성장을 견인하고 있습니다.

만성 통증 치료 시장의 주요 기업들은 비오피오이드 요법에 대한 수요 증가, 장기적인 통증 관리 개선, 환자 결과 개선에 대응하기 위해 폐쇄 루프 척수 자극(SCS) 시스템과 같은 첨단 솔루션 개발에 주력하고 있습니다. 폐쇄 루프 SCS 시스템은 이식 가능한 충전식 신경 자극 장치로, 신경 신호를 지속적으로 감지하여 실시간으로 전기 자극을 자동 조정합니다. 이는 미리 설정된 출력을 제공하는 기존의 오픈 루프 장치와 다릅니다. 예를 들어, 2024년 4월 아일랜드에 본사를 둔 의료기기 제조업체인 메드트로닉(Medtronic)은 미국 식품의약국(FDA)의 인셉티브 신경자극 시스템 승인을 받았습니다. 이 소형 이식형 장치는 감지 전극을 통해 유도된 신경 반응을 모니터링하고, 자극을 자동으로 조절합니다. 전신용 1.5T 및 3T MRI 호환이 가능하며, 임피던스 독립적인 감지 기능을 갖추고 있으며, 만성 난치성 체간 또는 사지 통증에 대한 적응증을 가지고 있습니다. 기존 고정 출력형 SCS 시스템과 비교하여 보다 일관된 통증 완화, 좋은 반응자 결과 및 향상된 편안함을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Chronic pain treatment refers to the ongoing management of pain that lasts for more than three months, often extending beyond the expected healing period. It typically involves a combination of medications, physical therapy, psychological support, and lifestyle modifications to reduce pain, improve function, and enhance quality of life.

The main product types for chronic pain include drugs and devices. Drugs for chronic pain target inflammation, nerve signals, or underlying causes to relieve persistent pain and improve patient well-being. They are used for conditions such as neuropathic pain, arthritis, chronic back pain, cancer pain, migraines, fibromyalgia, and others. These medications are distributed through direct and indirect channels and serve a range of end-users, including hospitals, clinics, nursing homes, research centers, universities, and more.

Tariffs have increased costs in the chronic pain treatment market by impacting imports of pain-relief drugs, neuromodulation devices, and implantable pain management systems. Device-based therapies and advanced pharmaceuticals are most affected, particularly in North America and Europe due to reliance on global medical device supply chains. Hospitals and clinics experience higher treatment expenses. However, tariffs are promoting domestic production of pain management drugs and devices, improving long-term market stability.

The chronic pain treatment market research report is one of a series of new reports from The Business Research Company that provides chronic pain treatment market statistics, including chronic pain treatment industry global market size, regional shares, competitors with a chronic pain treatment market share, detailed chronic pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain treatment industry. This chronic pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic pain treatment market size has grown strongly in recent years. It will grow from $109.05 billion in 2025 to $119.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to opioid usage, musculoskeletal disorders, aging population, hospital pain clinics, post-surgical pain management.

The chronic pain treatment market size is expected to see strong growth in the next few years. It will grow to $168.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to opioid regulation, device-based therapies, chronic disease prevalence, mental health integration, outpatient pain care growth. Major trends in the forecast period include shift toward non-opioid pain therapies, growth of neuromodulation devices, expansion of multidisciplinary pain management, increased focus on personalized pain care, integration of psychological support therapies.

The rising prevalence of arthritis pain is expected to drive the growth of the chronic pain treatment market in the coming years. Arthritis pain refers to discomfort, soreness, or aching in the joints caused by inflammation or degeneration associated with arthritis. The prevalence of arthritis pain is increasing primarily due to the aging population, as joint wear and tear naturally rise with age, resulting in a higher incidence of arthritis-related conditions. Chronic pain treatments address arthritis pain by targeting inflammation and nerve sensitivity, helping reduce discomfort, improve joint function, and enhance overall quality of life for individuals with persistent symptoms. For instance, in July 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, an estimated 21.2% of adults aged 18 and older in the United States were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is driving the growth of the chronic pain treatment market.

Major companies in the chronic pain treatment market are focusing on developing advanced solutions, such as closed-loop spinal cord stimulation (SCS) systems, to meet growing demand for non-opioid therapies, provide better long-term pain control, and improve patient outcomes. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously sense neural signals and automatically adjust electrical stimulation in real time, unlike traditional open-loop devices that deliver preset outputs. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. This compact implantable device monitors evoked neural responses using sensing electrodes and automatically adjusts stimulation. It provides full-body 1.5T and 3T MRI compatibility, features impedance-independent sensing, and is indicated for chronic, intractable trunk or limb pain. The system delivers more consistent pain relief, better responder outcomes, and improved comfort compared with traditional fixed-output SCS systems.

In May 2025, electroCore Inc., a US-based bioelectronic technology company, acquired NeuroMetrix Inc. for an undisclosed amount. Through this acquisition, electroCore aims to strengthen its position in the non-invasive bioelectronic therapy market by integrating NeuroMetrix's Quell platform, expanding product offerings, and accelerating growth in the chronic pain and wellness segments, particularly within the Veterans Affairs Hospital System. NeuroMetrix Inc. is a US-based medical technology company specializing in non-invasive therapeutic devices for chronic pain conditions such as fibromyalgia.

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pain treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy, psychological counseling, interventional pain management, alternative therapies, pain management clinics, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain treatment market also includes sales of lyrica, cymbalta, oxycontin, neurontin, voltaren gel, quell, and precision spectra spinal cord stimulator. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pain Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses chronic pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Drugs; Devices
• 2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
• 3) By Distribution channels: Direct; Indirect
• 4) By End-User: Hospitals; Clinics; Nursing Homes; Research Centers And Universities; Other End-Users
• Subsegments:
• 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Antidepressants; Anticonvulsants; Muscle Relaxants; Topical Analgesics; Other Pain Relief Medications
• 2) By Devices: Neuromodulation Devices; Transcutaneous Electrical Nerve Stimulation (TENS) Devices; Spinal Cord Stimulators; Peripheral Nerve Stimulators; Radiofrequency Ablation Devices; Implantable Drug Delivery Devices
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; Novartis AG; GlaxoSmithKline plc; Medtronic plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; Boston Scientific Corporation; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.; Amneal Pharmaceuticals LLC; Mallinckrodt plc; Nevro Corp.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Chronic Pain Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Chronic Pain Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Chronic Pain Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Chronic Pain Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Shift Toward Non-Opioid Pain Therapies
  • 4.2.2 Growth Of Neuromodulation Devices
  • 4.2.3 Expansion Of Multidisciplinary Pain Management
  • 4.2.4 Increased Focus On Personalized Pain Care
  • 4.2.5 Integration Of Psychological Support Therapies

5. Chronic Pain Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Nursing Homes
• 5.4 Pain Management Centers
• 5.5 Rehabilitation Facilities

6. Chronic Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Pain Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Chronic Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Chronic Pain Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Chronic Pain Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Chronic Pain Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Pain Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Pain Treatment Market Segmentation

• 9.1. Global Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drugs, Devices
• 9.2. Global Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
• 9.3. Global Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Direct, Indirect
• 9.4. Global Chronic Pain Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users
• 9.5. Global Chronic Pain Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications
• 9.6. Global Chronic Pain Treatment Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

10. Chronic Pain Treatment Market Regional And Country Analysis

• 10.1. Global Chronic Pain Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Chronic Pain Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chronic Pain Treatment Market

• 11.1. Asia-Pacific Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chronic Pain Treatment Market

• 12.1. China Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chronic Pain Treatment Market

• 13.1. India Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chronic Pain Treatment Market

• 14.1. Japan Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chronic Pain Treatment Market

• 15.1. Australia Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chronic Pain Treatment Market

• 16.1. Indonesia Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chronic Pain Treatment Market

• 17.1. South Korea Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chronic Pain Treatment Market

• 18.1. Taiwan Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chronic Pain Treatment Market

• 19.1. South East Asia Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chronic Pain Treatment Market

• 20.1. Western Europe Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chronic Pain Treatment Market

• 21.1. UK Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chronic Pain Treatment Market

• 22.1. Germany Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chronic Pain Treatment Market

• 23.1. France Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chronic Pain Treatment Market

• 24.1. Italy Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chronic Pain Treatment Market

• 25.1. Spain Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chronic Pain Treatment Market

• 26.1. Eastern Europe Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chronic Pain Treatment Market

• 27.1. Russia Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chronic Pain Treatment Market

• 28.1. North America Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chronic Pain Treatment Market

• 29.1. USA Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chronic Pain Treatment Market

• 30.1. Canada Chronic Pain Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chronic Pain Treatment Market

• 31.1. South America Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chronic Pain Treatment Market

• 32.1. Brazil Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chronic Pain Treatment Market

• 33.1. Middle East Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chronic Pain Treatment Market

• 34.1. Africa Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Chronic Pain Treatment Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chronic Pain Treatment Market Regulatory and Investment Landscape

36. Chronic Pain Treatment Market Competitive Landscape And Company Profiles

• 36.1. Chronic Pain Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Chronic Pain Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Chronic Pain Treatment Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Pain Treatment Market Other Major And Innovative Companies

• Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

38. Global Chronic Pain Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Chronic Pain Treatment Market

40. Chronic Pain Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Chronic Pain Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Chronic Pain Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Chronic Pain Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer